We conducted a comparative study of TGF-β-driven EMT in cultured CRPC cells and in CTCs and the enumeration of CTCs and accompanying host macrophages isolated from xenograft hosts and prostate cancer patients, respectively (Supplementary Figure S1). The gene discussed is TGFB1; the disease is prostate cancer.